India, U.S. vow to jointly act against emerging drug threats

India and the U.S. held the 2nd Drug Policy Executive Working Group meeting to coordinate efforts against transnational drug trafficking. The discussions focused on intelligence sharing, pharmaceutical supply chain integrity, and implementing India's Vision Roadmap 2026-2029.
Why it matters
Enhanced bilateral cooperation between India and the U.S. is critical for disrupting international narcotics networks and improving public health security.
New Delhi India and the U.S. agreed to undertake coordinated action to address emerging narcotic threats during a recently concluded high-level meeting in New Delhi. The Narcotics Control Bureau (NCB) hosted the 2nd India-United States of America Drug Policy Executive Working Group Meeting on November 2-3, the federal anti-narcotics agency said in a statement on Tuesday (November 10, 2026). The Indian delegation was led by NCB Director General (DG) Anurag, while the U.S. side was headed by Debbie Seguin, Acting Deputy Director, Office of National Drug Control Policy (ONDCP). What does the Centre’s Vision Document on Drug Control 2026-2029 propose? What does the Centre’s Vision Document on Drug Control 2026-2029 propose?
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in